【創新突圍｜英文特輯】CAR T-Cell Therapy: cancer treatment breakthrough

The CAR T-Cell Therapy, hailed as the "New Dawn in Blood Cancer Treatment," has seen significant progress. Since 2017, six CAR T-cell therapies have gained approval from the US Food and Drug Administration (FDA). Today, new possibilities are emerging from ongoing research by expert teams. What are the chances of curing blood? What actual cases in clinical practice can ameliorate the predicament of patients? Looking globally, Australia's government and its health department have established healthcare technology policies worth learning from. Tune in to this episode of "Innovative Breakthroughs" to grasp the latest medical trends.

Host：Ethan Liu
Guest：Professor Stephen Opat, Director of Clinical Haematology at Monash Health,Alex Huang, the VP and Head of Cell Therapy, BeiGene

Producers: CWLAB,Integrated Communication Dept.

This episode is sponsored by BeiGene.
--
Hosting provided by SoundOn